Mitoxantrone in malignant melanoma

Academic Article

Abstract

  • Twenty-nine patients with metastatic malignant melanoma without prior chemotherapy and 36 patients refractory to prior chemotherapy received mitoxantrone (5 mg/m2/week). No patient achieved a partial response. The dose-limiting toxic effect was granulocytopenia. Mitoxantrone is ineffective in malignant melanoma.
  • Published In

    Author List

  • Presant CA; Gams R; Bartolucci A
  • Start Page

  • 903
  • End Page

  • 905
  • Volume

  • 68
  • Issue

  • 6